Company intelligence / Profile preview

Sedgwick Yard

Ownership: Private
Development stage: Other

Overview

Sedgwick Yard is an active venture capital firm specializing in cross-border life science investments, focusing on innovative biotech startups with novel therapeutic modalities and facilitating their access to Asian markets. The firm actively supports its portfolio companies with strategic guidance and board representation.

Therapeutic areas: Other
Modalities: Monoclonal antibodyGene therapy
Industry: Investors

Partnerships

Invested in DJS AntibodiesInvested in Akamis Bio

Beyond the preview

Go deeper on Sedgwick Yard.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sedgwick Yard.

Explore the full profile